Nitric oxide inhibits neutrophil infiltration in the reverse passive Arthus reaction in rat skin

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 358, Issue 4, 1998, Pages 489-495

  Ianaro, Angela ^a   Ialenti, Armando ^a   Sautebin, Lidia ^a   Di Rosa, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Neutrophil infiltration; Nitric oxide; Reverse passive Arthus reaction; Vascular permeability

Indexed keywords

1 HYDROXY 2 OXO 3,3 BIS(3 AMONOETHYL) 1 TRIAZENE; ARGININE; N(G) METHYL DEXTRO ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; PHENYLPROPANOLAMINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VESSEL PERMEABILITY; EDEMA; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; NEUTROPHIL; SKIN; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; ARTHUS REACTION; CAPILLARY PERMEABILITY; GUANIDINES; HEMOGLOBINS; MALE; NEUTROPHILS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROSO COMPOUNDS; RATS; RATS, WISTAR;

EID: 0031680045     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005282     Document Type: Article

References (50)

1. Arndt H, Russel JM, Kurose I, Kubes P, Granger DN (1993) Mediators of leucocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology 105:675-680
2. Bailey PJ, Sturm A (1983) Immune complexes and inflammation. A study of the activity of anti-inflammatory drugs in the reverse passive Arthus reaction in the rat. Biochem Pharmacol 32:475-481
3. Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209
4. Cartwright JE, Johnstone AP, Whitley GSJ (1997) Inhibition of nitric oxide synthase by antisense techiques: investigation of the roles of NO produced by murine macrophages. Br J Pharmacol 120:146-152
5. Cochrane GC, Janoff A (1974) The Arthus reaction: a model of neutrophil and complement-mediated injury. In: Zweifach BW, Grant L, McCluskey RT (eds) The inflammatory process. Academic Press, New York, pp 85-162
6. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR Jr, Williamson JR, McDaniel ML (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-556
7. Crawford JP, Movat HZ, Narendranath SR, Hay JB (1982) Pathways to inflammation induced by immune complexes: development of the Arthus reaction. Fed Proc 41:2583-2587
8. Curran RD, Billiar TR, Stuehr DJ, Hofmann K, Simmons RL (1989) Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products from Kupffer cells. J Exp Med 170:1769-1774
9. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation. J Clin Invest 96:60-68
10. Di Rosa M, Ialenti A, Ianaro A, Sautebin L (1996) Interaction between nitric oxide and cyclooxygenase pathways. Prostaglandins Leukot Essent Fatty Acids 54:229-238
11. Erlansson M, Bergqvist D, Persson NH, Svensjo E (1991) Modification of postischemic increase of leucocyte adhesion and vascular permeability in the hamster by iloprost. Prostaglandins 41:157-168
12. Fantone JC, Ward PA (1982) Role of oxygen-derived free radicals and metabolites in leucocyte-dependent inflammatory reactions. Am J Pathol 107:398-418
13. Feelisch M, Stamler JS (1996) Donors of nitrogen oxides. In: Feelisch M, Stamler JS (eds) Methods in nitric oxide research. Wiley, Chichester, pp 71-115
14. Furchgott RF, Vanhoutte PM (1989) Endothelium-derived relaxing and contracting factors. FASEB J 3:2007-2018
15. Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P (1993) Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol 265:H862-H867
16. G-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol 101:10-12
17. Gauthier TW, Davenpeck KL, Lefer AM (1994) Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol 267:G562-G568
18. Granger DN (1988) Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 255:H1269-H1275
19. Griffith OW, Park KH, Aisaka K, Levi R, Gross SS (1992) The role of plasma arginine in nitric oxide synthesis: studies with arginase-treated guinea pigs and rats. In: Moncada S, Hibbs JB Jr, Higgs EA (eds) The biology of nitric oxide. I. Physiological and clinical aspects. Portland Press, London, pp 6-10
20. Hibbs JB Jr, Taintor RR, Rachlin EM (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157:87-94
21. Humphrey DM (1993) Measurement of cutaneous microvascular exudates using Evans Blue. Biotech Histochem 68:342-349
22. Johnson G, Tsao PS, Lefer AM (1990) Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 19:244-252
23. Kilbourn RG, Belloni P (1990) Endothelial cell production of nitrogen oxides in response to interferon-γ in combination with tumor necrosis factor, interleukin-1 or endotoxin. J Natl Cancer Inst 82:772-779
24. Knowles RG, Moncada S (1994) Nitric oxide synthases in mammals. Biochem J 298:249-258
25. Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655
26. Kubes P, Kanwar S, Niu X-F, Gaboury JP (1993) Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 7:1293-1299
27. Ma X, Weyrich AS, Lefer DJ, Lefer AM (1993) Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 72:403-412
28. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA, Keefer LK (1991) Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 34:3242-3247
29. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS (1988) Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27:8706-8711
30. McCall TB, Boughton-Smith NK, Palmer RMJ, Whittle BJR, Moncada S (1989) Synthesis of nitric oxide from L-arginine by neutrophils. Biochem J 261:293-296
31. Medeiros M, Biuhara IM, Moreno H Jr, Zatz R, De Nucci G, Antunes E (1995) Effect of chronic nitric oxide synthesis inhibition on the inflammatory responses induced by carrageenin in rats. Eur J Pharmacol 285:109-114
32. Moncada S, Palmer RMJ, Higgs A (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-141
33. Mulligan MS, Ward PA (1992) Immune complex-induced lung and dermal vascular injury. Differing requirements for tumor necrosis factor-α and IL-1. J Immunol 149:331-339
34. Mulligan MS, Hevel JM, Marletta MA, Ward PA (1991) Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA 88:6338-6342
35. Mulligan MS, Moncada S, Ward PA (1992a) Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br J Pharmacol 107:1159-1162
36. 2 integrins of rat neutrophils in complement- and oxygen radical-mediated acute inflammatory injury. J Immunol 148:1847-1857
37. Murad F (1986) Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 78:1-5
38. Niu X-F, Smith CW, Kubes P (1994) Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 74:1133-1140
39. Niu X-F, Ibbotson G, Kubes P (1996) A balance between nitric oxide and oxidants regulates mast-cell-dependent neutrophil-endothelial cell interactions. Circ Res 79:992-999
40. Norman KE, Argenbright LW, Williams TJ, Rossi AG (1994) Role of adhesion glycoproteins CD18 and intercellular adhesion molecule-1 in complement-mediated reactions of rabbit skin. Br J Pharmacol 111:117-122
41. Palmer RMJ, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666
42. Perretti M (1997) Endogenous mediators that inhibit the leucocyte-endothelium interaction. Trends Pharmacol Sci 18:418-425
43. Radomski MW, Palmer RMJ, Moncada S (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2:1057-1058
44. Rampart M, Williams TJ (1988) Evidence that neutrophil accumulation induced by interleukin-1 requires both local protein biosynthesis and neutrophil CD18 antigen expression in vivo. Br J Pharmacol 94:1143-1148
45. Salvemini D, Manning PT, Zweifel BS, Seibert K, Connor J, Currie MG, Needleman P, Masferrer J (1995a) Dual inhibition of nitric oxide and prostaglandin production contributes to the anti-inflammatory properties ot nitric oxide synthase inhibitors. J Clin Invest 96:301-308
46. Salvemini D, Settle SL, Masferrer JL, Seibert K, Currie MG, Needleman P (1995b) Regulation of prostaglandin production by nitric oxide, an in vivo analysis. Br J Pharmacol 114:1171-1178
47. Schierwagen C, Bylund-Fellenius AC, Lundberg C (1990) Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 23:179-186
48. Southan GJ, Szabo C, Thiemermann C (1995) Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 114:510-516
49. Teixeira MM, Williams TJ, Hellewell PG (1993) Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br J Pharmacol 110:1515-1521
50. Teixeira MM, Fairbairn SM, Norman KE, Williams TJ, Rossi AG, Hellewell PG (1994) Studies on the mechanisms involved in the inflammatory response in a reversed passive Arthus reaction in guinea-pig skin: contribution of neutrophil and endogenous mediators. Br J Pharmacol 113:1363-1371